TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
TARA

Protara Therapeutics Inc

Healthcare · Biotechnology

3.50$ -3.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Protara Therapeutics Inc (TARA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 176 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TARA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
88 79 68 102 94 181 169 157 145 209 192 176
78 69 58 92 85 172 127 125 136 160 140 146
34 40 52 90 52 163 91 31 13 50 15 17
74 66 55 90 81 170 124 122 133 156 136 17
0.3 0.2 0.0 0.4 0.9 1.0 1.3 1.5
-0.3
2.7 2.6 2.6 2.5 3.2 3.1 3.0 3.0 2.9 5.9 5.8
12 11 9.7 9.6 12 14 10 13 12 13 11 15
6.8 6.1 5.5 5.6 8.6 11 7.0 9.8 9.9 11 8.9 13
1.0 1.0 1.0 1.0 1.1 1.1 1.2 1.2 1.2 1.2 1.3 1.3
2.5 2.4 1.0 1.4 2.3 4.4 2.3 5.3 4.5 3.5 4.0 4.7
77 68 58 92 82 167 158 144 132 196 181 161
-190 -200 -211 -221 -232 -245 -257 -272 -285 -302 -320 -342
11 11 11 21 22 26 41 42 42 46 58 61

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?